Parkinson’s Patients Report Using Cannabis Largely for Symptom Relief in U.S. Survey

Nearly a quarter of patients with Parkinson’s disease polled in a U.S. national survey reported using cannabis mainly to try and ease their symptoms, despite a lack of evidence on both its effectiveness and safety.

Although still federally illegal, marijuana has been legalized for either recreational or medicinal use in 33 states in the U.S., 13 of which list Parkinson’s as a qualifying condition for medical purposes.

This wider availability means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.

– Read the entire article at Parkinson’s News Today.

Read More Here...

Patients Prefer Medicinal Cannabis In Chemotherapy Trial

Medicinal cannabis has been shown to make a difference for cancer patients to relieve the side-effects of chemotherapy.

Early results of a landmark trial involving 80 patients at the Chris O’Brien Lifehouse hospital show that cannabis capsules were better than placebo at improving symptoms.

“An extra one in 10 people had control of nausea and vomiting, so it had improved from 14 per cent to 25 per cent,” said Associate Professor Peter Grimison, a medical oncologist at Chris O’Brien Lifehouse.

– Read the entire article at 9 News.

Read More Here...

Delta-8 THC: Is It Legal and What Is It Good For?

Delta-8 THC is a minor cannabinoid known to be an analog of delta-9 THC — the most abundant cannabinoid found in marijuana.

The molecular structures of the two cannabinoids are similar, albeit with some significant differences.

For starters, delta-8 THC has a far lower psychotropic effect than delta-9 THC. This might be due to the fact that, unlike D9 THC, D8 THC interacts with both the CB1 and CB2 receptors in the human endocannabinoid system (ECS). CBD, which also interacts with CB2 is known to reduce the psychotropic effects of THC.

Delta-8 THC, unlike delta-9 THC, is not produced directly by cannabinoid-synthesizing enzymes in the plant. Rather, special breeding and molecular isolation are applied by growers and extractors to produce larger quantities of delta-8. It can be produced in both marijuana and hemp.

Because it is produced in such minute….Read Full Article Here

Prepare Your Cannabis Business for the TCPA

For some reason, many cannabis businesses believe that because they’re already violating the federal Controlled Substances Act, they’re free to violate other existing federal laws. This of course is not the case, and never has been. Even though cannabis businesses can’t get legitimate recognition or fair treatment from the Department of Justice or the Drug Enforcement Administration, it doesn’t mean that they’re otherwise exempt from compliance with existing federal laws, including consumer protection laws that apply to all businesses throughout the United States.

The latest legal debacle for unwitting cannabis businesses are violations of the Telephone Consumer Protection Act (“TCPA“). Plaintiffs’ lawyers are quickly recognizing how vulnerable/unaware cannabis businesses are when it comes to TCPA compliance.

Passed by Congress in 1991, the TCPA is a strict liability statute designed to fight incessant “robocalls” and aggressive/abusive telemarketers that plague unconsenting consumers. The TCPA provides, in relevant part:

It shall be unlawful for any person within the United States, or any person outside the United States if the recipient is within the United States … to make any call (other than a call made for emergency purposes or made with the prior express consent of the called party) using any

Read More Here...

House Democrats Postpone Cannabis Legalization Bill Until Post-Election

“At a time when people are really struggling just to pay the bills and to get through this health crisis, [COVID relief] should be our priority.”

Don’t expect any bills that would legalize cannabis to receive floor votes until after the November election.

TheMarijuana, Opportunity, Reinvestment and Expungement (MORE) Act,which would have effectively legalized cannabis nationwide and expunged cannabis-related records, was set for a vote this month in the House of Representatives, but that won’t happen until later this year.

– Read the entire article at The London Free Press.

Read More Here...

Cannabis Consumption Surges During Pandemic As Sleep Issues And Anxieties Mount, Says New Poll

Since the onset of the COVID-19 pandemic, there has been a nearly double-digit increase in cannabis consumption among users as well as a “massive, lasting uptick” in those turning to cannabis delivery services to deal with sleep issues and rising anxieties. These are two key findings according to a new poll conducted by California-based Ganja Goddess, an online shopping, delivery and lifestyle brand that caters to cannabis consumers statewide.

The study, which polled more than 850 people, also found that flower is the primary method of consuming cannabis and that convenience and safety were top reasons for selecting a delivery service.

Zachary Pitts, CEO of Ganja Goddess, said in a public statement that the poll’s findings show “a lasting shift in consumer behavior as the pandemic goes on and consumer behaviors evolve, which is reflected in the more than 100 percent growth year-over-year we are experiencing.” Pitts added that the majority (55 percent) of respondents consuming cannabis during the ongoing pandemic increased by 9 percent since Ganja Goddess conducted its last poll in April 2020.

– Read the entire article at Forbes.

Read More Here...

Dominion Strike Leaves Central Newfoundland Shoppers With No Cannabis Retailer

Critics say it shows a gap in legalization, and people are heading to the illegal market.

The almost four-week-old Dominion strike is turning into a major buzzkill for cannabis enthusiasts in central Newfoundland, who have been left with no retail outlets for miles.

Dominion was granted the only two initial retail licenses for cannabis sales in the area, and the store’s contract dispute with Unifor Local 597 has led to the closure of both establishments — as well as eight others across the province.

“It’s just a big bummer all around, really,” said Jennifer Warren of Gambo. “You gotta order stuff online — and with COVID, too, the mail thing slows everything down.”

– Read the entire article at CBC News.

Read More Here...

French Committee Pushes for Cannabis Legalization

Throughout all the major cannabis news that has been making headlines in Europe, the U.S., and across the globe over the past ten or so years, France has been almost nowhere in the mix.

A parliamentary committee wants to change that as soon as possible and the members are urging the government to initiate a medical cannabis experiment and figure out the best way to address medical cannabis concerns. 

An Urgent Call To Action

The committee made this demand in a document, asking for a budget that would support some kind of experiment surrounding medical cannabis and its potential for legalization. 

“It’s very important that funding for the medical cannabis experiment is now integrated into this process,” said  Benjamin-Alexandre Jeanroy, CEO of Augur Associates in Paris, back in 2019 regarding the importance of moving forward and making something happen. While France has technically approved such an experiment a year ago through legal channels, there needs to be actual implementation to get something off the ground and into the trial stage so that progress can be monitored.  

Robin Reda of the French National Assembly and president of the committee claims that she believes France “has fallen alarmingly behind its European neighbors”

Read More Here...

Congress Delays Vote On MORE Act

Democratic leaders in the House of Representatives have delayed a vote on a marijuana decriminalization bill that was scheduled for next week, bowing to pressure from moderates in the party who want lawmakers to focus first on COVID-19 pandemic relief efforts. A vote on the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act will instead occur later this year, according to party leadership.

“Right now, the House is focused relentlessly on securing agreement to stave off a damaging government shutdown and continuing to do its job addressing the COVID-19 pandemic,” House Majority Leader Steny H. Hoyer said in a statement. “Later this autumn, the House will pass the MORE Act with strong support as yet another crucial step toward making our justice system fair for all Americans.”

If passed, the bill would decriminalize marijuana at the federal level and allow the states to set their own cannabis regulation policies. The bill would also expunge convictions for many federal marijuana-related offenses and levy a 5% commercial cannabis tax which would be invested in communities that have borne the brunt of the harm caused by the failed War on Drugs.

“The MORE Act remains a critical component of House Democrats’ plan for addressing

Read More Here...

A Bipartisan Bill Would Regulate Hemp CBD as a Dietary Supplement

Last week, Oregon Representative Kurt Schrader (D) and Virginia Representative Morgan Griffith (R) introduced The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (“H.R. 8179”). If enacted in its current form, H.R. 8179 would legalize the manufacture, sale and marketing of hemp, hemp-derived cannabidiol and other hemp extracts (collectively referred to as “Hemp Products”) as dietary supplements under the Federal Food, Drug and Cosmetic Act (“FDCA”).

This means that these products would be exempt from the FDCA’s “Drug Exclusion Rule,” which, as we previously discussed, currently prevents the sale and marketing of any substance that has been approved or investigated by the FDA as a new drug as a conventional food or dietary supplement – In July 2018, the FDA approved CBD as a drug ingredient in Epidiolex.

To be compliant with the FDCA, these Hemp Products would need to meet the existing regulatory framework imposed on dietary supplements. This comprehensive regulatory framework mandates, in part, that these products be safe as well as properly labeled and marketed.

Because Hemp Products were not sold and marketed in the U.S. as dietary supplements or conventional foods before October 15, 1994, they would be deemed “new dietary

Read More Here...